
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research.
The global Biobanking Services market is projected to reach US$ 8631.3 million in 2029, increasing from US$ 5115.6 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2029.
Global biobanking marketÌýwas valued at $16.5 billion in 2017, and is estimated to reach $23.6 billion by 2025, with a CAGR of 4.6% from 2018 to 2025.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biobanking Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Qiagen N.V.
Hamilton
Brooks Automation
TTP Labtech
VWR
Promega
LGC
Boca Biolistics
Thermo Fisher
Segment by Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Segment by Application
Regenerative Medicine
Life Science
Clinical Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biobanking Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biobanking Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood Products
1.2.3 Human Tissues
1.2.4 Cell Lines
1.2.5 Nucleic Acids
1.3 Market by Application
1.3.1 Global Biobanking Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Regenerative Medicine
1.3.3 Life Science
1.3.4 Clinical Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biobanking Services Market Perspective (2018-2029)
2.2 Biobanking Services Growth Trends by Region
2.2.1 Global Biobanking Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biobanking Services Historic Market Size by Region (2018-2023)
2.2.3 Biobanking Services Forecasted Market Size by Region (2024-2029)
2.3 Biobanking Services Market Dynamics
2.3.1 Biobanking Services Industry Trends
2.3.2 Biobanking Services Market Drivers
2.3.3 Biobanking Services Market Challenges
2.3.4 Biobanking Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biobanking Services Players by Revenue
3.1.1 Global Top Biobanking Services Players by Revenue (2018-2023)
3.1.2 Global Biobanking Services Revenue Market Share by Players (2018-2023)
3.2 Global Biobanking Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biobanking Services Revenue
3.4 Global Biobanking Services Market Concentration Ratio
3.4.1 Global Biobanking Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biobanking Services Revenue in 2022
3.5 Biobanking Services Key Players Head office and Area Served
3.6 Key Players Biobanking Services Product Solution and Service
3.7 Date of Enter into Biobanking Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biobanking Services Breakdown Data by Type
4.1 Global Biobanking Services Historic Market Size by Type (2018-2023)
4.2 Global Biobanking Services Forecasted Market Size by Type (2024-2029)
5 Biobanking Services Breakdown Data by Application
5.1 Global Biobanking Services Historic Market Size by Application (2018-2023)
5.2 Global Biobanking Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biobanking Services Market Size (2018-2029)
6.2 North America Biobanking Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biobanking Services Market Size by Country (2018-2023)
6.4 North America Biobanking Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biobanking Services Market Size (2018-2029)
7.2 Europe Biobanking Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biobanking Services Market Size by Country (2018-2023)
7.4 Europe Biobanking Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biobanking Services Market Size (2018-2029)
8.2 Asia-Pacific Biobanking Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biobanking Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Biobanking Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biobanking Services Market Size (2018-2029)
9.2 Latin America Biobanking Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biobanking Services Market Size by Country (2018-2023)
9.4 Latin America Biobanking Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biobanking Services Market Size (2018-2029)
10.2 Middle East & Africa Biobanking Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biobanking Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Biobanking Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Detail
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Biobanking Services Introduction
11.1.4 Qiagen N.V. Revenue in Biobanking Services Business (2018-2023)
11.1.5 Qiagen N.V. Recent Development
11.2 Hamilton
11.2.1 Hamilton Company Detail
11.2.2 Hamilton Business Overview
11.2.3 Hamilton Biobanking Services Introduction
11.2.4 Hamilton Revenue in Biobanking Services Business (2018-2023)
11.2.5 Hamilton Recent Development
11.3 Brooks Automation
11.3.1 Brooks Automation Company Detail
11.3.2 Brooks Automation Business Overview
11.3.3 Brooks Automation Biobanking Services Introduction
11.3.4 Brooks Automation Revenue in Biobanking Services Business (2018-2023)
11.3.5 Brooks Automation Recent Development
11.4 TTP Labtech
11.4.1 TTP Labtech Company Detail
11.4.2 TTP Labtech Business Overview
11.4.3 TTP Labtech Biobanking Services Introduction
11.4.4 TTP Labtech Revenue in Biobanking Services Business (2018-2023)
11.4.5 TTP Labtech Recent Development
11.5 VWR
11.5.1 VWR Company Detail
11.5.2 VWR Business Overview
11.5.3 VWR Biobanking Services Introduction
11.5.4 VWR Revenue in Biobanking Services Business (2018-2023)
11.5.5 VWR Recent Development
11.6 Promega
11.6.1 Promega Company Detail
11.6.2 Promega Business Overview
11.6.3 Promega Biobanking Services Introduction
11.6.4 Promega Revenue in Biobanking Services Business (2018-2023)
11.6.5 Promega Recent Development
11.7 LGC
11.7.1 LGC Company Detail
11.7.2 LGC Business Overview
11.7.3 LGC Biobanking Services Introduction
11.7.4 LGC Revenue in Biobanking Services Business (2018-2023)
11.7.5 LGC Recent Development
11.8 Boca Biolistics
11.8.1 Boca Biolistics Company Detail
11.8.2 Boca Biolistics Business Overview
11.8.3 Boca Biolistics Biobanking Services Introduction
11.8.4 Boca Biolistics Revenue in Biobanking Services Business (2018-2023)
11.8.5 Boca Biolistics Recent Development
11.9 Thermo Fisher
11.9.1 Thermo Fisher Company Detail
11.9.2 Thermo Fisher Business Overview
11.9.3 Thermo Fisher Biobanking Services Introduction
11.9.4 Thermo Fisher Revenue in Biobanking Services Business (2018-2023)
11.9.5 Thermo Fisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Qiagen N.V.
Hamilton
Brooks Automation
TTP Labtech
VWR
Promega
LGC
Boca Biolistics
Thermo Fisher
Ìý
Ìý
*If Applicable.
